Contact us now for a free consultation with one of our HIFU experts!

call us today!
877-766-8400

HIFU Outcomes During 15 Years

Purpose We describe the long-term cancer control and morbidity of high intensity focused ultrasound with neoadjuvant transurethral resection of the prostate, the risk of metastatic induction by transurethral prostate resection, and the evolution of high intensity focused ultrasound application and technology with time. Materials and Methods A prospective Harlaching high intensity focused ultrasound database was … Continue reading “HIFU Outcomes During 15 Years”


FDA Approval for Ablatherm HIFU

EDAP Receives FDA Approval for Ablatherm HIFU LYON, France, Nov. 9, 2015 (GLOBE NEWSWIRE) — EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Ablatherm® Integrated Imaging HIFU in the U.S. for the ablation of prostate tissue. EDAP … Continue reading “FDA Approval for Ablatherm HIFU”


Robotic high-intensity focused ultrasound for prostate cancer: what have we learned in 15 years of clinical use?

Curr Urol Rep. 2011 Jun;12(3):180-7. doi: 10.1007/s11934-011-0184-2. Robotic high-intensity focused ultrasound for prostate cancer: what have we learned in 15 years of clinical use? Chaussy CG1, Thüroff SF. Abstract High-intensity focused ultrasound (HIFU) is an emerging, noninvasive, local treatment of prostate cancer with 15 years of clinical experience, during which about 30,000 HIFU treatments have … Continue reading “Robotic high-intensity focused ultrasound for prostate cancer: what have we learned in 15 years of clinical use?”


HIFU advantages

Sarasota welcomes the very first HIFU center in America!Sarasota welcomes the very first Ablatherm HIFU center.

Sarasota welcomes the very first HIFU center in America!Sarasota welcomes the very first Ablatherm HIFU center.


Call or Email us today for more information about HIFU* (with an Asterisk)! Our Niche Market at HCOA is treating Aggressive Prostate Cancer with predictable excellence!